Cantel Medical Named to the Forbes 2009 List of the '200 Best Small Companies in America'

Share Name	Share Symbol	Market	Type
Cantel Medical Corp.	NYSE:CMN	NYSE	Common Stock

Share Name

Share Symbol

Market

Type

Cantel Medical Corp.

NYSE:CMN

NYSE

Common Stock

	Price Change	% Change	Share Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	0.00	0.00%	81.14				0	01:00:00

Price Change

% Change

Share Price

High Price

Low Price

Open Price

Shares Traded

Last Trade

0.00

0.00%

81.14

01:00:00

Cantel Medical Named to the Forbes 2009 List of the '200 Best Small Companies in America'

20/10/2009 7:49pm

PR Newswire (US)

Cantel (NYSE:CMN)
Historical Stock Chart

From Jun 2019 to Jun 2024

LITTLE FALLS, N.J., Oct. 20 /PRNewswire-FirstCall/ -- Cantel Medical Corp. (NYSE:CMN) announced today that it was named to the Forbes 2009 list of the "200 Best Small Companies in America." Cantel Medical has been included on this list in eight of the last ten years. Cantel's President and CEO, Andrew Krakauer stated, "We are pleased to have been recognized for the success the Company has achieved both this year and over the past five years. I share this honor with our 870 hardworking and loyal employees. As a leader in the growing infection prevention and control market, the Company has performed well despite the difficult economic environment. We are optimistic that Cantel is positioned for sustained growth in the future as it will continue to benefit from increased sales of higher margin consumables, including disinfectants, sterilants and face masks, as well as increases in service. These recurring revenues now make up 75% of overall sales." The Forbes rankings are based on one and five-year sales growth, earnings per share growth and return on equity. To qualify, companies must have sales between $5 million and $750 million, and meet certain share price and other criteria. Forbes also compares a company's stock performance with its industry peers. About Cantel Medical Corp. Cantel Medical Corp. (NYSE:CMN) is a leading provider of infection prevention and control products in the healthcare market. Our products include specialized medical device reprocessing systems for renal dialysis and endoscopy, dialysate concentrates and other dialysis supplies, disposable infection prevention and control products primarily for the dental industry, water purification equipment, sterilants, disinfectants and cleaners, hollow fiber membrane filtration and separation products for medical and non-medical applications, and specialty packaging for infectious and biological specimens. We also provide technical maintenance for our products and offer compliance training services for the transport of infectious and biological specimens. For more information please visit http://www.cantelmedical.com/. This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks and uncertainties, including, without limitation, the risks detailed in Cantel's filings and reports with the Securities and Exchange Commission. Such forward-looking statements are only predictions, and actual events or results may differ materially from those projected or anticipated. DATASOURCE: Cantel Medical Corp. CONTACT: Andrew A. Krakauer, President and CEO, Cantel Medical Corp., +1-973-890-7220, or Richard E. Moyer, Cameron Associates, Inc., , +1-212-554-5466 Web Site: http://www.cantelmedical.com/

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

CMN Cantel Medical Corp.